Add to my calendar2021-04-27 19:00:002021-04-27 20:00:00AstraZeneca optimizing anti-inflammatory reliever therapy
Please join us virtually for a presentation on optimizing anti-inflammatory reliever therapy: anti-inflammatory reliever reduces exacerbations. A fundamental change in approach to treating asthma. This program is supported in part by an educational grant from AstraZeneca.
Speakers:
Dr. Jaspreet Kambo
Moderator: Dr. Servaas Swart
Learning objectives:
Describe the latest asthma treatment recommendations from the Global, Initiative for Asthma (GINA) and the Canadian Thoracic Society (CTS)
Discuss why over-reliance on short-acting beta-agonists (SABA) increases risk of exacerbations and worsening asthma
Discuss recent evidence on anti-inflammatory reliever reducing asthma exacerbations
Identify strategies to transition patients from SABA as a reliever to anti-inflammatory reliever
How to join:
Registration required https://us02web.zoom.us/meeting/register/tZMpceyoqzkrGNJuYyey8cqiyO7iGI81uiCB
after registering, you will receive a confirmation email containing the zoom information to join.
CME: This one-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the British Columbia Chapter for 1.0 Mainpro+ credit.
Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.
Online Event
Physician Educationphysician.education@northernhealth.caAmerica/Vancouverpublic
Add to Calendar: Start date2021-04-27 19:00:002024-05-19 03:42:36TitleDescriptionLocationPhysiciansrajbir.singh@opin.caAmerica/Vancouverpublic
Add to Calendar: End Date2024-05-19 03:42:362021-04-27 20:00:00AstraZeneca optimizing anti-inflammatory reliever therapy
Dr. Jaspreet Kambo presents on anti-inflammatory reliever reduces exacerbations.
Online Event
Physiciansrajbir.singh@opin.caAmerica/Vancouverpublic
Please join us virtually for a presentation on optimizing anti-inflammatory reliever therapy: anti-inflammatory reliever reduces exacerbations. A fundamental change in approach to treating asthma. This program is supported in part by an educational grant from AstraZeneca.
Speakers:
Dr. Jaspreet Kambo
Moderator: Dr. Servaas Swart
Learning objectives:
Describe the latest asthma treatment recommendations from the Global, Initiative for Asthma (GINA) and the Canadian Thoracic Society (CTS)
Discuss why over-reliance on short-acting beta-agonists (SABA) increases risk of exacerbations and worsening asthma
Discuss recent evidence on anti-inflammatory reliever reducing asthma exacerbations
Identify strategies to transition patients from SABA as a reliever to anti-inflammatory reliever
CME: This one-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the British Columbia Chapter for 1.0 Mainpro+ credit.
Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.